EXBX(EXBX)
EXBX
11/13/26
Exobox Technologies (EXBX)
Friday
9:46 AM ET
ThesisThe recent strategic partnerships and product enhancements have significantly improved the growth outlook, leading to increased investor confidence.
Revenue Outlook
| Metric | FY2009 | FY2010 |
|---|---|---|
| Revenue | $0.00 | $14.4K |
| Rev. Growth | — | — |
| EPS | $-0.02 | $-0.01 |
| EPS Growth | -100% | +50.0% |
| P/E | — | — |
What’s Driving the Stock
- 01Exobox's recent partnership with a leading healthcare provider is expected to increase ARR by 25% over the next year.
- 02The company is developing a new AI-driven analytics tool that could reduce customer churn by 15%.
- 03Recent enhancements to the software platform have led to a 30% increase in user engagement metrics.
- 04A shift in focus towards enterprise clients could lead to a 40% increase in average deal size.
- 05AI-driven analytics growth
- 06Increased demand for data security solutions
- 07Adoption rates of machine learning applications in enterprise sectors
- 08Changes in data privacy regulations impacting software demand
FY2010 Snapshot
- Revenue
- $14.4K
- Gross Margin
- -107%
- Op. Margin
- -31560%
- Net Margin
- -31477%
- Net Income
- $-5M
- NI Growth
- +30.0%
- EPS
- $-0.01
- 1Y Return
- +0.0%
EXBX Chart
My Notes
- "Our commitment to innovation and strategic partnerships positions us well for sustained growth."
- Moat: Exobox's proprietary algorithms create a strong competitive advantage that is difficult for competitors to replicate.
- growth - Investors are likely attracted to the potential for rapid revenue growth in the tech sector.
- Low - As a software company, Exobox is less sensitive to interest rate fluctuations…
- Watch on earnings: Annual recurring revenue (ARR), Customer retention rate, Market share in the data analytics sector.
One Sentence Summary:
Exobox Technologies: the setup is constructive — exobox's recent partnership with a leading healthcare provider is expected to increase arr by 25% over the next year.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.
Explore More
EXBX Financial Metrics
Explore 130+ historical metrics & ratios
Stock Comparison
Compare equities side by side
52-Week Highs Breakout
Stocks breaking to new annual highs
52-Week Lows Oversold
S&P 500 oversold value screener
Trending Momentum
Relative strength momentum leaders
Earnings Calendar
Upcoming earnings dates & reports
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance